Detection of myocardial infarction - is it all troponin?: point

Cardiac troponin is a cardiospecific protein that is detectable in the blood of patients with myocardial injury with sensitive and specific assays (1). Cardiac troponin is recommended as the preferred biomarker for the diagnosis of myocardial infarction (MI),2 for risk stratification, and for therap...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Giannitsis, Evangelos (VerfasserIn) , Katus, Hugo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2012
In: Clinical chemistry
Year: 2011, Jahrgang: 58, Heft: 1, Pages: 158-161
ISSN:1530-8561
DOI:10.1373/clinchem.2011.168575
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1373/clinchem.2011.168575
Verlag, kostenfrei, Volltext: http://clinchem.aaccjnls.org/content/58/1/158
Volltext
Verfasserangaben:Evangelos Giannitsis and Hugo A. Katus

MARC

LEADER 00000caa a2200000 c 4500
001 1576185168
003 DE-627
005 20220814155830.0
007 cr uuu---uuuuu
008 180608r20122011xx |||||o 00| ||eng c
024 7 |a 10.1373/clinchem.2011.168575  |2 doi 
035 |a (DE-627)1576185168 
035 |a (DE-576)506185168 
035 |a (DE-599)BSZ506185168 
035 |a (OCoLC)1341011325 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Giannitsis, Evangelos  |e VerfasserIn  |0 (DE-588)113336241  |0 (DE-627)577184091  |0 (DE-576)289759579  |4 aut 
245 1 0 |a Detection of myocardial infarction - is it all troponin?  |b point  |c Evangelos Giannitsis and Hugo A. Katus 
246 3 3 |a Point: Detection of myocardial infarction - is it all troponin 
264 1 |c 2012 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.06.2018 
500 |a Published online December 28, 2011 
520 |a Cardiac troponin is a cardiospecific protein that is detectable in the blood of patients with myocardial injury with sensitive and specific assays (1). Cardiac troponin is recommended as the preferred biomarker for the diagnosis of myocardial infarction (MI),2 for risk stratification, and for therapeutic guidance regarding anticoagulation therapy and invasive management (2-4). Assays should be appropriately precise to measure at the 99th-percentile value with a total imprecision of ≤10%. Until recently, assays were insufficiently precise, and rather than using the recommended 99th-percentile value, many clinicians had advocated the use of the lowest value at which an assay achieved a 10% CV as the decision cutoff. Manufacturers have refined their assays through improvements in reagent or antibody configuration, changes in the microparticle capture bed, introduction of a third antibody, increases in sample volume, and other modifications (5). For these reasons, newer generations of cardiac troponin assays now provide improved analytical sensitivity and precision.High-sensitivity cardiac troponin assays have reduced the time from symptom onset to detectable marker increases compared with former assays. Keller et al. (6) demonstrated that a contemporary sensitive cardiac troponin I (cTnI) assay allowed a diagnosis of MI on admission in an acute coronary syndrome (ACS) population with a sensitivity of 90.7% and a negative predictive value (NPV) of 96.4%. A second sample 3 h after symptom onset identified all patients with a final MI diagnosis, irrespective of the time delay from onset of symptoms to presentation. Reichlin et al. (7) evaluated 786 consecutive patients with suspected ACS and demonstrated better performance of 4 cardiac troponin assays more sensitive than the conventional fourth-generation cTnT assay, with sensitivities at presentation of between 84% and 95% (NPVs, 97%-99%). Both trials indicated that the benefits of earlier detection were most pronounced for patients presenting early after chest pain … 
534 |c 2011 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
773 0 8 |i Enthalten in  |t Clinical chemistry  |d Washington, DC : American Association for Clinical Chemistry, 1955  |g 58(2012), 1, Seite 158-161  |h Online-Ressource  |w (DE-627)266883117  |w (DE-600)1468161-4  |w (DE-576)075146401  |x 1530-8561  |7 nnas  |a Detection of myocardial infarction - is it all troponin? point 
773 1 8 |g volume:58  |g year:2012  |g number:1  |g pages:158-161  |g extent:4  |a Detection of myocardial infarction - is it all troponin? point 
856 4 0 |u http://dx.doi.org/10.1373/clinchem.2011.168575  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://clinchem.aaccjnls.org/content/58/1/158  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180608 
993 |a Article 
994 |a 2012 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |e 910000PK108916618  |e 910100PK108916618  |k 0/910000/  |k 1/910000/910100/  |p 2  |y j 
998 |g 113336241  |a Giannitsis, Evangelos  |m 113336241:Giannitsis, Evangelos  |d 910000  |d 910100  |e 910000PG113336241  |e 910100PG113336241  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1576185168  |e 3012229132 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"titleAlt":[{"title":"Point: Detection of myocardial infarction - is it all troponin"}],"language":["eng"],"note":["Gesehen am 08.06.2018","Published online December 28, 2011"],"physDesc":[{"extent":"4 S."}],"id":{"doi":["10.1373/clinchem.2011.168575"],"eki":["1576185168"]},"title":[{"title":"Detection of myocardial infarction - is it all troponin?","subtitle":"point","title_sort":"Detection of myocardial infarction - is it all troponin?"}],"origin":[{"dateIssuedDisp":"2012","dateIssuedKey":"2012"}],"relHost":[{"note":["Gesehen am 26.08.2021"],"pubHistory":["1.1955 -"],"language":["eng"],"part":{"text":"58(2012), 1, Seite 158-161","pages":"158-161","extent":"4","issue":"1","volume":"58","year":"2012"},"disp":"Detection of myocardial infarction - is it all troponin? pointClinical chemistry","type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"American Association of Clinical Chemists","role":"isb"}],"recId":"266883117","origin":[{"publisherPlace":"Washington, DC ; Oxford","dateIssuedKey":"1955","dateIssuedDisp":"1955-","publisher":"American Association for Clinical Chemistry ; Oxford University Press"}],"title":[{"subtitle":"journal of the American Association for Clinical Chemistry ; international journal of laboratory medicine and molecular diagnostics","title":"Clinical chemistry","title_sort":"Clinical chemistry"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1530-8561"],"eki":["266883117"],"zdb":["1468161-4"]}}],"name":{"displayForm":["Evangelos Giannitsis and Hugo A. Katus"]},"recId":"1576185168","person":[{"display":"Giannitsis, Evangelos","given":"Evangelos","role":"aut","family":"Giannitsis"},{"family":"Katus","role":"aut","given":"Hugo","display":"Katus, Hugo"}]} 
SRT |a GIANNITSISDETECTIONO2012